Display options
Share it on

Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11729-34. doi: 10.1073/pnas.96.21.11729.

Peroxynitrite reaction products of 3',5'-di-O-acetyl-8-oxo-7, 8-dihydro-2'-deoxyguanosine.

Proceedings of the National Academy of Sciences of the United States of America

J C Niles, S Burney, S P Singh, J S Wishnok, S R Tannenbaum

Affiliations

  1. Division of Bioengineering and Environmental Health, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

PMID: 10518518 PMCID: PMC18354 DOI: 10.1073/pnas.96.21.11729

Abstract

Of the DNA bases, peroxynitrite (ONOO-) is most reactive toward 2'-deoxyguanosine (dGuo), but even more reactive with 8-oxo-7, 8-dihydro-2'-deoxyguanosine (8-oxodGuo), requiring a 1,000-fold excess of dGuo to provide 50% protection against the reaction with 8-oxodGuo. Therefore, it seems reasonable that 8-oxodGuo is a potentially important target in DNA and that the structures of the reaction products with ONOO- should be characterized. Using 3', 5'-di-O-Ac-8-oxodGuo as a model compound, the reaction products with ONOO- have been isolated and identified under simulated physiological reaction conditions (phosphate/bicarbonate buffer at pH 7.2). The major reaction product, II, is unstable and undergoes base-mediated hydrolysis to 2,5-diaminoimidazol-4-one, IIa, and 3-(3, 5-di-O-Ac-2-deoxy-beta-D-erythro-pentofuranosyl)-5-iminoimidazolidine -2,4-dione, IIb. The latter compound further hydrolyzes to 3-(3, 5-di-O-Ac-2-deoxy-beta-D-erythro-pentofuranosyl)oxaluric acid, IIc. Other products include 3-(3, 5-di-O-Ac-2-deoxy-beta-D-erythro-pentofuranosyl)-2,4,6-trioxo-[1,3, 5]triazinane-1-carboxamidine, I, which further hydrolyzes to 1-(3, 5-di-O-Ac-2-deoxy-beta-D-erythro-pentofuranosyl)cyanuric acid, Ia. 1-(3,5-di-O-Ac-2-deoxy-beta-D-erythro-pentofuranosyl)parabanic acid, III, is a minor product that also may contribute to formation of IIc. The major products formed in these reactions are biologically uncharacterized but are similar to modified DNA bases that have been shown to be both premutagenic and blocks to DNA polymerization.

References

  1. Free Radic Biol Med. 1996;21(3):407-11 - PubMed
  2. Chem Res Toxicol. 1996 Jan-Feb;9(1):3-7 - PubMed
  3. FEBS Lett. 1996 Dec 9;399(1-2):67-70 - PubMed
  4. Chem Res Toxicol. 1997 Apr;10(4):386-92 - PubMed
  5. Free Radic Biol Med. 1997;23(2):331-8 - PubMed
  6. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):288-93 - PubMed
  7. Chem Res Toxicol. 1992 Nov-Dec;5(6):834-42 - PubMed
  8. Chem Res Toxicol. 1992 May-Jun;5(3):425-31 - PubMed
  9. Arch Biochem Biophys. 1991 Aug 1;288(2):481-7 - PubMed
  10. J Biol Chem. 1991 Mar 5;266(7):4244-50 - PubMed
  11. J Med Chem. 1985 Sep;28(9):1194-8 - PubMed
  12. Chem Pharm Bull (Tokyo). 1965 Sep;13(9):1140-2 - PubMed
  13. Nucleic Acids Res. 1984 Feb 24;12(4):2137-45 - PubMed
  14. Carcinogenesis. 1995 Sep;16(9):2045-50 - PubMed
  15. Mutat Res. 1993 May;299(3-4):147-56 - PubMed
  16. Am J Respir Crit Care Med. 1995 Apr;151(4):1250-4 - PubMed
  17. Arch Biochem Biophys. 1992 Nov 1;298(2):446-51 - PubMed
  18. Chem Res Toxicol. 1999 May;12(5):459-66 - PubMed
  19. FEBS Lett. 1995 May 15;364(3):279-82 - PubMed
  20. Am J Physiol. 1995 May;268(5 Pt 1):L699-722 - PubMed
  21. Biochem Biophys Res Commun. 1995 May 25;210(3):1025-30 - PubMed
  22. Biochemistry. 1995 Mar 21;34(11):3544-52 - PubMed
  23. Free Radic Biol Med. 1995 Jan;18(1):75-83 - PubMed
  24. J Clin Invest. 1994 Dec;94(6):2407-13 - PubMed
  25. FEBS Lett. 1994 Jul 18;348(3):223-7 - PubMed
  26. FEBS Lett. 1994 Jul 18;348(3):287-90 - PubMed
  27. FEBS Lett. 1994 Aug 15;350(1):9-12 - PubMed
  28. Free Radic Res Commun. 1993;18(4):195-9 - PubMed
  29. Arch Biochem Biophys. 1996 Mar 15;327(2):335-43 - PubMed
  30. Biochemistry. 1996 Jun 18;35(24):7855-61 - PubMed
  31. Free Radic Res. 1996 May;24(5):369-80 - PubMed
  32. Chem Res Toxicol. 1996 Jul-Aug;9(5):845-50 - PubMed

Publication Types

Grant support